The Valley Desk

NCT02561988 · Interventional trial

(EXPLORER) Study of BLU-285 in Patients With Advanced Systemic Mastocytosis (AdvSM) and Relapsed or Refractory Myeloid Malignancies

Overall registry status Completed

Phase 1

Conditions Aggressive Systemic Mastocytosis, Mast Cell Leukemia, Relapsed or Refractory Myeloid Malignancies, Systemic Mastocytosis-associated Hematologic Non-mast Cell Disease

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov